Molina Healthcare, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the Annual Meeting of Stockholders held by Molina Healthcare, Inc. on May 8, 2019. The filing date is May 13, 2019. The company is a Delaware corporation with its principal executive offices in Long Beach, California.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and stockholder voting results.
Material Changes and Voting Results
At the meeting, 58,120,531 shares were voted, representing 92.80% of the 62,629,548 shares outstanding as of the March 11, 2019 record date. Stockholders approved all six proposals submitted:
- Proposal 1 (Election of Directors): Three Class II directors (Barbara L. Brasier, Steven J. Orlando, Richard C. Zoretic) were elected to serve until the 2022 annual meeting.
- Proposal 2 (Executive Compensation): Stockholders approved the non-binding advisory vote on named executive officer compensation.
- Proposal 3 (Board Structure): Stockholders approved amendments to the Certificate of Incorporation to eliminate the classified Board of Directors, transitioning to the annual election of all directors.
- Proposal 4 (Equity Incentive Plan): The 2019 Equity Incentive Plan was approved.
- Proposal 5 (Employee Stock Purchase Plan): The 2019 Employee Stock Purchase Plan was approved.
- Proposal 6 (Auditor Ratification): The appointment of Ernst & Young LLP as the independent registered public accounting firm for 2019 was ratified.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors related to operations. The primary corporate action noted is the structural change to the Board of Directors to allow for annual elections.
Key Facts for Investor Verification
- Verify the implementation timeline for the transition from a classified to an annually elected Board of Directors.
- Review the specific terms of the newly approved 2019 Equity Incentive Plan and Employee Stock Purchase Plan.
- Confirm the re-election of the three Class II directors and their tenure through 2022.
- Note that the filing contains no financial data; refer to the most recent 10-Q or 10-K for financial performance.